Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig R Lee

Showing results (61-70 of 122) with videos related to

Pageof 13
Sort By:
American Journal of Physiology. Endocrinology and Metabolism|December 22, 2011
Enalapril reverses high-fat diet-induced alterations in cytochrome P450-mediated eicosanoid metabolismKatherine N Theken, Yangmei Deng, Robert N Schuck, et al.
American Journal of Pharmaceutical Education|July 20, 2021
Implementation and Initial Evaluation of a Research and Scholarship Training Pathway in a Doctor of Pharmacy CurriculumKathryn A Morbitzer, Jacqueline E McLaughlin, Sachiko Ozawa, et al.
Prostaglandins & Other Lipid Mediators|October 9, 2012
Cytochrome P450 2J2 is protective against global cerebral ischemia in transgenic miceRui Li, Xizhen Xu, Chen Chen, et al.
Pharmacogenomics|January 27, 2022
Pharmacogenomic prescribing opportunities in percutaneous coronary intervention and bone marrow transplant patientsLindsay Ratner, Jing 'Daisy' Zhu, Megan N Gower, et al.
Clinical Pharmacology and Therapeutics|May 15, 2026
Impact of CYP2C19 and CYP3A4 Inhibitor Use on Clopidogrel Clinical Effectiveness in CYP2C19 Genotyped Patients Undergoing Percutaneous Coronary InterventionDanwei Shao, Jean G Malavé, Joseph S Rossi, et al.
Clinical Pharmacology and Therapeutics|March 20, 2020
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory DrugsKatherine N Theken, Craig R Lee, Li Gong, et al.
North Carolina Medical Journal|February 4, 2014
A renaissance in pharmacy education at the University of North Carolina at Chapel HillMary T Roth, Russell J Mumper, Scott F Singleton, et al.
Frontiers in Pharmacology|December 12, 2025
Estrogen associations with human pregnancy related increases in cytochrome P450 3A activityMuluneh M Fashe, Jonghwa Lee, Joseph T Grieco, et al.
Human Molecular Genetics|April 6, 2006
Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) studyCraig R Lee, Kari E North, Molly S Bray, et al.
Clinical Pharmacology and Therapeutics|April 22, 2022
Use of Real-World Data and Physiologically-Based Pharmacokinetic Modeling to Characterize Enoxaparin Disposition in Children With ObesityJacqueline G Gerhart, Fernando O Carreño, Matthew Shane Loop, et al.
Pageof 13

Showing results (61-70 of 122) with videos related to

Sort By:
Pageof 13
American Journal of Physiology. Endocrinology and Metabolism|December 22, 2011
Enalapril reverses high-fat diet-induced alterations in cytochrome P450-mediated eicosanoid metabolismKatherine N Theken, Yangmei Deng, Robert N Schuck, et al.
American Journal of Pharmaceutical Education|July 20, 2021
Implementation and Initial Evaluation of a Research and Scholarship Training Pathway in a Doctor of Pharmacy CurriculumKathryn A Morbitzer, Jacqueline E McLaughlin, Sachiko Ozawa, et al.
Prostaglandins & Other Lipid Mediators|October 9, 2012
Cytochrome P450 2J2 is protective against global cerebral ischemia in transgenic miceRui Li, Xizhen Xu, Chen Chen, et al.
Pharmacogenomics|January 27, 2022
Pharmacogenomic prescribing opportunities in percutaneous coronary intervention and bone marrow transplant patientsLindsay Ratner, Jing 'Daisy' Zhu, Megan N Gower, et al.
Clinical Pharmacology and Therapeutics|May 15, 2026
Impact of CYP2C19 and CYP3A4 Inhibitor Use on Clopidogrel Clinical Effectiveness in CYP2C19 Genotyped Patients Undergoing Percutaneous Coronary InterventionDanwei Shao, Jean G Malavé, Joseph S Rossi, et al.
Clinical Pharmacology and Therapeutics|March 20, 2020
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory DrugsKatherine N Theken, Craig R Lee, Li Gong, et al.
North Carolina Medical Journal|February 4, 2014
A renaissance in pharmacy education at the University of North Carolina at Chapel HillMary T Roth, Russell J Mumper, Scott F Singleton, et al.
Frontiers in Pharmacology|December 12, 2025
Estrogen associations with human pregnancy related increases in cytochrome P450 3A activityMuluneh M Fashe, Jonghwa Lee, Joseph T Grieco, et al.
Human Molecular Genetics|April 6, 2006
Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) studyCraig R Lee, Kari E North, Molly S Bray, et al.
Clinical Pharmacology and Therapeutics|April 22, 2022
Use of Real-World Data and Physiologically-Based Pharmacokinetic Modeling to Characterize Enoxaparin Disposition in Children With ObesityJacqueline G Gerhart, Fernando O Carreño, Matthew Shane Loop, et al.
Pageof 13